Pub Date : 2022-11-13DOI: 10.5604/01.3001.0016.1620
Berenika Maciejewicz
The lack of standardized, efficient, and dependable lucid dream induction methods is one of the major barriers to studying the clinical and non-clinical applications of dream lucidity. Although the interest in therapeutic usage of lucid dreaming strategies in neuroscience of consciousness studies has increased in recent decades, many of the current induction approaches appear to not be replicable reliably. In this study, a new protocol for bringing on lucid dreaming was created, implemented, analyzed, and contrasted with two distinct other approaches. Techniques to induce dream lucidity include reality testing methods, the wake-and-go-to-bed technique, mnemonic initiation, senses-initiation, and a combination of the above. Before beginning their 2 weeks of lucid dream induction new protocol study, a total of 36 participants filled out a pre-test survey, maintained a dream recall diary and sleep log for the duration of the experiment, and completed a final survey. The findings showed that both the mnemonic induction and senses-initiation techniques were mildly effective in bringing about lucid dreaming. The new hybrid protocol, combining the reality check stra- tegy with dream recall amplification, performed significantly better. For lucid dream induction to work optimally, participants needed to become more proficient at remembering their dreams after waking up, so they were requested to maintain a sleep journal for 7 days before the experiment and throughout the study to enhance their ability to dream recall. There was no correlation found between the quality of one's sleep and the frequency of dream lucidity. The results demonstrated that the new induction protocol was more successful than the other two investigated methods. There are many clinical applications for dream lucidity, such as treatment of recurring and debilitating nightmares, narcolepsy, and PTSD. Therapeu- tic potential also includes future usage for anesthesia awareness and locked-in syndrome. As such, further dream lucidity research remains important.
{"title":"NEUROSCIENCE OF SLEEP AND COGNITION: INVESTIGATING THE EFFECTIVENESS OF THE NEW DREAM LUCIDITY INDUCTION PROTOCOL – A PILOT STUDY","authors":"Berenika Maciejewicz","doi":"10.5604/01.3001.0016.1620","DOIUrl":"https://doi.org/10.5604/01.3001.0016.1620","url":null,"abstract":"The lack of standardized, efficient, and dependable lucid dream induction methods is one of the major barriers to studying the clinical and non-clinical applications of dream lucidity. Although the interest in therapeutic usage of lucid dreaming strategies in neuroscience of consciousness studies has increased in recent decades, many of the current induction approaches appear to not be replicable reliably.\u0000\u0000In this study, a new protocol for bringing on lucid dreaming was created, implemented, analyzed, and contrasted with two distinct other approaches. Techniques to induce dream lucidity include reality testing methods, the wake-and-go-to-bed technique, mnemonic initiation, senses-initiation, and a combination of the above. Before beginning their 2 weeks of lucid dream induction new protocol study, a total of 36 participants filled out a pre-test survey, maintained a dream recall diary and sleep log for the duration of the experiment, and completed a final survey.\u0000\u0000The findings showed that both the mnemonic induction and senses-initiation techniques were mildly effective in bringing about lucid dreaming. The new hybrid protocol, combining the reality check stra- tegy with dream recall amplification, performed significantly better. For lucid dream induction to work optimally, participants needed to become more proficient at remembering their dreams after waking up, so they were requested to maintain a sleep journal for 7 days before the experiment and throughout the study to enhance their ability to dream recall. There was no correlation found between the quality of one's sleep and the frequency of dream lucidity.\u0000\u0000The results demonstrated that the new induction protocol was more successful than the other two investigated methods. There are many clinical applications for dream lucidity, such as treatment of recurring and debilitating nightmares, narcolepsy, and PTSD. Therapeu- tic potential also includes future usage for anesthesia awareness and locked-in syndrome. As such, further dream lucidity research remains important.\u0000\u0000","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49493924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-25DOI: 10.5604/01.3001.0015.9804
M. Pąchalska, Jolanta Góral-Półrola, Paulina Jarosz
There is growing evidence to support the view that a variety of neurological, neurocognitive and neuropsychiatric sequelae occur following SARS-CoV-2 infection and NeuroCovid 19. Furthermore, scholars report that various syndromes, including Parkinson's disease (PD), can develop within a short period of time following on from COVID-19. Although the mechanism of this phenomenon is not fully understood and it is not known whether this is in fact an acceleration of the development of PD already 'smouldering' in the body or related to a viral infection, these patients need rehabilitation assistance. Recently, as adjuvant therapy, transcranial direct current stimulation (tDCS) has been shown to improve the motor and non-motor function of patients with Parkinson's disease (PD), including neurocognitive impairment and therefore potentially change their quality of life. The aim of this article is to show the effectiveness of tDCS in the treatment of the patient with newly diagnosed Parkinson's disease after infection with the SARS-CoV-2 virus and the contracting of NeuroCovid 19, and equally developing long COVID. The motivation would be to help other patients with a similar situation during the COVID-19 pandemic. A 62-year-old man, an academic Art Teacher, was infected with SARS-CoV-2 and contracted NeuroCOVID-19 on November 11, 2021. Initially, he lost his sense of smell (anosmia), of taste (ageusia), developed headaches, and dizziness. After 10 days of illness, the patient developed severe, level two infextion (according to Wise 2020), and he was hospitalized, sedated and mechanically ventilated for 30 days. After discharge from hospital, the patient was still weak with different symptoms. Four months later he was diagnosed with long COVID and also the neurodegenerative disease PD (according to the DSM-5 criteria). He received levodopa therapy, and was referred to the Reintegration and Training Center of the Polish Neuropsychological Society for further treatment. The functional neuromarker, that is hypoactivation of the left dorsolateral prefrontal cortex (DLPFC), obtained with the use of QEEG/ERPs was helpful in choosing the appropriate tDCS protocol. Neurostimulation with the use of anodal tDCS over these area of the brain was administered systematically for 20 days. He also received individual sessions of art therapy for 20 day. After the treatment the patient improved and returned to his previous work as a university art teacher. The proposed anodal tDCS over the left dorsolateral prefrontal cortex (DLPFC), in combination with goal-oriented individual art therapy, offered to the patient, was effective in the reduction of all his syndromes. ERPs can be useful in the diagnosis and treatment of patients following infection by SARS-CoV-2 who contracted COVID-19, developed long COVID and additionally PD. It allows for the detection of the functional neuromarker of PD (e.g., hypoactivation of the dorsolateral prefrontal cortex, DLPFC) and enabled the
{"title":"NEUROTHERAPY IN PARKINSON’S DISEASE: THE PATH FORWARD AFTER SARS-COV-2 INFECTION AND CONTRACTING COVID-19, AND LONG COVID?","authors":"M. Pąchalska, Jolanta Góral-Półrola, Paulina Jarosz","doi":"10.5604/01.3001.0015.9804","DOIUrl":"https://doi.org/10.5604/01.3001.0015.9804","url":null,"abstract":"There is growing evidence to support the view that a variety of neurological, neurocognitive and neuropsychiatric sequelae occur following SARS-CoV-2 infection and NeuroCovid 19. Furthermore, scholars report that various syndromes, including Parkinson's disease (PD), can develop within a short period of time following on from COVID-19. Although the mechanism of this phenomenon is not fully understood and it is not known whether this is in fact an acceleration of the development of PD already 'smouldering' in the body or related to a viral infection, these patients need rehabilitation assistance. Recently, as adjuvant therapy, transcranial direct current stimulation (tDCS) has been shown to improve the motor and non-motor function of patients with Parkinson's disease (PD), including neurocognitive impairment and therefore potentially change their quality of life. The aim of this article is to show the effectiveness of tDCS in the treatment of the patient with newly diagnosed Parkinson's disease after infection with the SARS-CoV-2 virus and the contracting of NeuroCovid 19, and equally developing long COVID. The motivation would be to help other patients with a similar situation during the COVID-19 pandemic.\u0000\u0000A 62-year-old man, an academic Art Teacher, was infected with SARS-CoV-2 and contracted NeuroCOVID-19 on November 11, 2021. Initially, he lost his sense of smell (anosmia), of taste (ageusia), developed headaches, and dizziness. After 10 days of illness, the patient developed severe, level two infextion (according to Wise 2020), and he was hospitalized, sedated and mechanically ventilated for 30 days. After discharge from hospital, the patient was still weak with different symptoms. Four months later he was diagnosed with long COVID and also the neurodegenerative disease PD (according to the DSM-5 criteria). He received levodopa therapy, and was referred to the Reintegration and Training Center of the Polish Neuropsychological Society for further treatment. The functional neuromarker, that is hypoactivation of the left dorsolateral prefrontal cortex (DLPFC), obtained with the use of QEEG/ERPs was helpful in choosing the appropriate tDCS protocol. Neurostimulation with the use of anodal tDCS over these area of the brain was administered systematically for 20 days. He also received individual sessions of art therapy for 20 day. After the treatment the patient improved and returned to his previous work as a university art teacher. The proposed anodal tDCS over the left dorsolateral prefrontal cortex (DLPFC), in combination with goal-oriented individual art therapy, offered to the patient, was effective in the reduction of all his syndromes.\u0000\u0000ERPs can be useful in the diagnosis and treatment of patients following infection by SARS-CoV-2 who contracted COVID-19, developed long COVID and additionally PD. It allows for the detection of the functional neuromarker of PD (e.g., hypoactivation of the dorsolateral prefrontal cortex, DLPFC) and enabled the","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45362945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-25DOI: 10.5604/01.3001.0015.9833
Armin Ramic, Irma Cehic, Sanela Rustempasic, D. Malec, H. Memišević
Neuromyths are prevalent in all spheres of life and can be found in all professions. The teaching profession is especially susceptible to neuromyths as teachers want to provide the most effective, science-based instruction to their students. Sometimes these instructions are not based on scientific studies but on a misinterpretation of scientific findings or neuromyths. The goal of the present paper was to examine the prevalence of seven popular neuromyths in teachers in Bosnia and Herzegovina (BIH). The sample for this study comprised 300 teachers from all parts of BIH. The research material comprised 300 teachers (232 females and 62 males) from all parts of BIH. Participants were either personally invited to the study or recruited through an online survey sent to schools throughout BIH and teacher organizations. As a method we used the Questionnaire consisting of basic demographic information on the participants (gender, working experience, type of teacher) and 7 neuromyths statements on which participants were asked to answer whether they think the statement is true, not true, or they do not know. The results of this study indicate a wide prevalence of neuromyths in BIH teachers. The prevalence ranged from 17% to 82%. The most prevalent myth is about learning styles, while the least prevalent was that drinking less than 8 glasses of water causes a brain to shrink. There were statistically significant differences in the prevalence of neuromyths in relation to the teachers’ gender for every statement. However, the trend is not uniform. Although, overall the neuromyths were more prevalent in female teachers (for 5 items), for two neuromyth statements, male teachers had a higher prevalence. Additionally, the prevalence of neuromyths was more frequent in early-grade teachers. It should be noted that there are also differences in the results obtained for the different types of neuromyths. Neuroscience is important for education and for the teachers. Thus, more attention should be given to the process of translating neuroscientific findings into useful facts for teachers. One way to improve this process is through the continual professional development of teachers in the field of neuroscience.
{"title":"WE ONLY USE 10% OF OUR BRAINS AND OTHER NEUROMYTHS – A SURVEY OF TEACHERS IN BOSNIA AND HERZEGOVINA","authors":"Armin Ramic, Irma Cehic, Sanela Rustempasic, D. Malec, H. Memišević","doi":"10.5604/01.3001.0015.9833","DOIUrl":"https://doi.org/10.5604/01.3001.0015.9833","url":null,"abstract":"Neuromyths are prevalent in all spheres of life and can be found in all professions. The teaching profession is especially susceptible to neuromyths as teachers want to provide the most effective, science-based instruction to their students. Sometimes these instructions are not based on scientific studies but on a misinterpretation of scientific findings or neuromyths. The goal of the present paper was to examine the prevalence of seven popular neuromyths in teachers in Bosnia and Herzegovina (BIH).\u0000\u0000The sample for this study comprised 300 teachers from all parts of BIH. The research material comprised 300 teachers (232 females and 62 males) from all parts of BIH. Participants were either personally invited to the study or recruited through an online survey sent to schools throughout BIH and teacher organizations. As a method we used the Questionnaire consisting of basic demographic information on the participants (gender, working experience, type of teacher) and 7 neuromyths statements on which participants were asked to answer whether they think the statement is true, not true, or they do not know.\u0000\u0000The results of this study indicate a wide prevalence of neuromyths in BIH teachers. The prevalence ranged from 17% to 82%. The most prevalent myth is about learning styles, while the least prevalent was that drinking less than 8 glasses of water causes a brain to shrink. There were statistically significant differences in the prevalence of neuromyths in relation to the teachers’ gender for every statement. However, the trend is not uniform. Although, overall the neuromyths were more prevalent in female teachers (for 5 items), for two neuromyth statements, male teachers had a higher prevalence. Additionally, the prevalence of neuromyths was more frequent in early-grade teachers. It should be noted that there are also differences in the results obtained for the different types of neuromyths.\u0000\u0000Neuroscience is important for education and for the teachers. Thus, more attention should be given to the process of translating neuroscientific findings into useful facts for teachers. One way to improve this process is through the continual professional development of teachers in the field of neuroscience.\u0000\u0000","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43729061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-25DOI: 10.5604/01.3001.0016.0235
H. Sanchooli, H. Ghalenow, M. Rahnama
Being infected with the new Covid-19 disease in addition to physical risks, leads to difficult and different psychological experiences due to the nature and specific features of the disease. Successful patient management requires a comprehensive understanding of patients' experiences. This study was conducted to explain the experiences of patients with Covid- 19 using content analysis approach. This is a qualitative study with a conventional content analysis approach. Purposeful sampling was performed in 10 Janu ary to 25 April 2021with the participation of 10 patients with Covid-19 referred to convalescent home No. 1 in Zahedan southeast of Iran. Semi-structured interview was used to collect data, which was analyzed according to the steps proposed by Graneheim and Lundman method. Data analysis resulted in the formation of a main theme; “patient’s resilient efforts in the rampage of coronavirus”, as well as three categories and 7 subcategories. The main categories included; the basis for spread of coronavirus, breaking free from fears under the protection of spirituality, and mutual support between patient and family. It seems that patients with Covid-19 were trying to resist the coronavirus by resorting to spirituality and family support, so the "patients' resilient efforts in the rampage of coronavirus" was identified as the main theme of this study.
{"title":"PATIENT’S RESILIENT EFFORTS IN THE RAMPAGE OF CORONAVIRUS EXPERIENCES OF COVID-19 PATIENTS: A QUALITATIVE STUDY","authors":"H. Sanchooli, H. Ghalenow, M. Rahnama","doi":"10.5604/01.3001.0016.0235","DOIUrl":"https://doi.org/10.5604/01.3001.0016.0235","url":null,"abstract":"Being infected with the new Covid-19 disease in addition to physical risks, leads to difficult and different psychological experiences due to the nature and specific features of the disease. Successful patient management requires a comprehensive understanding of patients' experiences. This study was conducted to explain the experiences of patients with Covid- 19 using content analysis approach.\u0000\u0000This is a qualitative study with a conventional content analysis approach. Purposeful sampling was performed in 10 Janu ary to 25 April 2021with the participation of 10 patients with Covid-19 referred to convalescent home No. 1 in Zahedan southeast of Iran. Semi-structured interview was used to collect data, which was analyzed according to the steps proposed by Graneheim and Lundman method.\u0000\u0000Data analysis resulted in the formation of a main theme; “patient’s resilient efforts in the rampage of coronavirus”, as well as three categories and 7 subcategories. The main categories included; the basis for spread of coronavirus, breaking free from fears under the protection of spirituality, and mutual support between patient and family.\u0000\u0000It seems that patients with Covid-19 were trying to resist the\u0000coronavirus by resorting to spirituality and family support, so\u0000the \"patients' resilient efforts in the rampage of coronavirus\"\u0000was identified as the main theme of this study.\u0000\u0000","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46517468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-25DOI: 10.5604/01.3001.0015.9832
Aboubacar Abderemane, T. M. Ahmadou, Siham Belbachir, Khalid Barkat, Ahmed Omar Touhami Ahami
Cannabis, as the most widely used illicit substance in the world, also remains among the most frequently used psychoactive substances by patients with schizophrenia. It is well known that cannabis use in schizophrenia patients favors relapse, resistance to antipsychotic treatments and therefore more frequent hospitalizations. However, many studies report considerable improvement in cognitive performance in substance users, while others show the opposite. Hence, the aim of our study is to examine the relationship between schizophrenia and cannabis use in clinical and socio-de- mographic aspects. This is a cross-sectional study of patients with schizophrenia hospitalized for relapse at the Ar-Razi psychiatric hospital in Salé, Morocco. A questionnaire was established in order to search for socio- demographic data, evolutionary and prognostic criteria of the disease. Cannabis use was assessed using the Cannabis Abuse Screening Test (CAST), for the severity of schizophrenia symptoms we used the Positive And Negative Syndrome Scale (PANSS) and for perceptual and memory abilities we used the numerical version of the Rey's Complex Figure-A (RCF-A). It was found that in a sample of 115 schizophrenic patients, 47.82% (n=55) were cannabis users. The mean PANSS (negative) and (general psychopathology) scores of non-cannabis users were significantly higher than those of cannabis users with P values of (P<0.001) and (P<0.005) respectively. For the numerical assessment scores of the RCF-A, cannabis users had a significantly higher mean score than non-cannabis users (copy phase (P<0.016) and memory (P<0.001) As one of the leading risk factors for the emergence of schizophre- nia, chronic cannabis use also has a negative influence on the prognosis of patients already suffering from schizophrenia. Nevertheless, the results of our study show that cannabis-using schizophrenic patients had fewer negative symptoms according to the PANSS and an improved cognitive performance compared to non- cannabis-using patients.
{"title":"STUDY OF THE IMPACT OF CANNABIS USE ON PERCEPTUAL AND MEMORY PROCESSES AS WELL AS ON\u0000POSITIVE AND NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA","authors":"Aboubacar Abderemane, T. M. Ahmadou, Siham Belbachir, Khalid Barkat, Ahmed Omar Touhami Ahami","doi":"10.5604/01.3001.0015.9832","DOIUrl":"https://doi.org/10.5604/01.3001.0015.9832","url":null,"abstract":"Cannabis, as the most widely used illicit substance in the world, also remains among the most frequently used psychoactive substances by patients with schizophrenia. It is well known that cannabis use in schizophrenia patients favors relapse, resistance to antipsychotic treatments and therefore more frequent hospitalizations. However, many studies report considerable improvement in cognitive performance in substance users, while others show the opposite. Hence, the aim of our study is to examine the relationship between schizophrenia and cannabis use in clinical and socio-de- mographic aspects.\u0000\u0000This is a cross-sectional study of patients with schizophrenia hospitalized for relapse at the Ar-Razi psychiatric hospital in Salé, Morocco. A questionnaire was established in order to search for socio- demographic data, evolutionary and prognostic criteria of the disease. Cannabis use was assessed using the Cannabis Abuse Screening Test (CAST), for the severity of schizophrenia symptoms we used the Positive And Negative Syndrome Scale (PANSS) and for perceptual and memory abilities we used the numerical version of the Rey's Complex Figure-A (RCF-A).\u0000\u0000It was found that in a sample of 115 schizophrenic patients, 47.82% (n=55) were cannabis users. The mean PANSS (negative) and (general psychopathology) scores of non-cannabis users were significantly higher than those of cannabis users with P values of (P<0.001) and (P<0.005) respectively. For the numerical assessment scores of the RCF-A, cannabis users had a significantly higher mean score than non-cannabis users (copy phase (P<0.016) and memory (P<0.001)\u0000\u0000As one of the leading risk factors for the emergence of schizophre- nia, chronic cannabis use also has a negative influence on the prognosis of patients already suffering from schizophrenia. Nevertheless, the results of our study show that cannabis-using schizophrenic patients had fewer negative symptoms according to the PANSS and an improved cognitive performance compared to non- cannabis-using patients.\u0000\u0000","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48962606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-25DOI: 10.5604/01.3001.0016.0115
C. Basterfield, S. Zondo
Despite advances in combination antiretroviral therapy (cARTs), children in Sub-Saharan Africa continue to experience neurocognitive deficits due to the virus crossing the blood-brain barrier (BBB). Based on the principles of neuroplasticity, our study sought to investigate the feasibility of introducing a pencil and paper cognitive rehabilitation tool called Brainwave-R, to ameliorate the effects of HIV neurocognition amongst children from a low socioeconomic background in rural South Africa. Five HIV positive and six HIV negative children were assigned to either an experimental or control group. The experimental group underwent two months of cognitive rehabilitation therapy to remediate sustained attention, using Brainwave-R, whereas the noncontact control group took part in placebo activities. Sustained attention measures were taken before and after the intervention training sessions, using a sustained attention subtest. The control group later received cognitive intervention three months following the conclusion of the research study. A Mann Whitney U Test revealed that the experimental group (Mdn=38.50) did not differ significantly from the control group (Mdn=37.00) after the cognitive rehabilitation intervention, U= 12.00, z= -.55, p= 0.66, r= -0.17. A Wilcoxon Signed Rank Test found that there was a significant improvement from pretest scores (Mdn=31.00) to post test scores (Mdn=38.00) following the rehabilitation for HIV positive participants in the sample, T=15.00, z = -2.02, p= 0.04, r= -0.90. The findings of our study raise the feasibility of a pencil and paper cognitive rehabilitation method to supplement antiretroviral (ARV) therapy in paediatric HIV.
{"title":"A FEASIBILITY STUDY EXPLORING THE EFFICACY OF COGNITIVE REHABILITATION THERAPY FOR PAEDIATRIC HIV IN RURAL SOUTH AFRICA: A FOCUS ON SUSTAINED ATTENTION","authors":"C. Basterfield, S. Zondo","doi":"10.5604/01.3001.0016.0115","DOIUrl":"https://doi.org/10.5604/01.3001.0016.0115","url":null,"abstract":"Despite advances in combination antiretroviral therapy (cARTs), children in Sub-Saharan Africa continue to experience neurocognitive deficits due to the virus crossing the blood-brain barrier (BBB). Based on the principles of neuroplasticity, our study sought to investigate the feasibility of introducing a pencil and paper cognitive rehabilitation tool called Brainwave-R, to ameliorate the effects of HIV neurocognition amongst children from a low socioeconomic background in rural South Africa.\u0000\u0000Five HIV positive and six HIV negative children were assigned to either an experimental or control group. The experimental group underwent two months of cognitive rehabilitation therapy to remediate sustained attention, using Brainwave-R, whereas the noncontact control group took part in placebo activities. Sustained attention measures were taken before and after the intervention training sessions, using a sustained attention subtest. The control group later received cognitive intervention three months following the conclusion of the research study.\u0000\u0000A Mann Whitney U Test revealed that the experimental group (Mdn=38.50) did not differ significantly from the control group (Mdn=37.00) after the cognitive rehabilitation intervention, U= 12.00, z= -.55, p= 0.66, r= -0.17. A Wilcoxon Signed Rank Test found that there was a significant improvement from pretest scores (Mdn=31.00) to post test scores (Mdn=38.00) following the rehabilitation for HIV positive participants in the sample, T=15.00, z = -2.02, p= 0.04, r= -0.90.\u0000\u0000The findings of our study raise the feasibility of a pencil and paper cognitive rehabilitation method to supplement antiretroviral (ARV) therapy in paediatric HIV.\u0000\u0000","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41502063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-25DOI: 10.5604/01.3001.0016.0760
M. Legmouz, A. El Ouahabi, S. Boulbaroud, F. Azzaoui
Brain tumours refer to all tumors, both benign and malignant, which develop in the cerebral parenchyma. In Africa, including Morocco, there is a paucity of descriptive brain tumors data. The aim of this study to describe the epidemiological profile of brain tumors types among Moroccan adolescents. Our study is a descriptive epidemiological study targeting all ado- lescent patients, aged between 10 and 19, suffering from a brain tumor and admitted from January 1 to December 31, 2020, to the neuro- surgery department of the Hospital of Specialities-CHU-Rabat-Mo- rocco. During these period, the neurosurgery department admitted 179 patients diagnosed with a brain tumor, including 18 adolescents, which represents 10.05% of all admitted patients. The 18 teenagers found include 11 females patients and 7 males patients which means a sex-ratio Male/Female of 0,64. The average age of our patients is 13.05 years, with extremities ranging from 10 to 19 years. It was found that for the topographic distribution 50% of tumors are infratentorial and 50% are supratentorial. The most presented re- vealing symptomatology is headaches (12 patients, 66.67%). The other symptoms experienced by patients were fatigability (11 patients), diziness (10 patients), vomiting (8 patients), weightloss (8 patients), seizures (6 patients), visual disturbances (5 patients), balance disorder (4 patients), hemiparesis (3 patients), hypoacusis (2 patients) and other. We found that Astrocytomas come in first position of diagnosed tumors with a percentage of 22.22% followed by Vestibular schwannoma and Craniopharyngioma with a percentage of 16.67% each. The topographic diagnosis finds an infra-tentorial localization equal to the supratentorial localization with 50% each. A rare tumor was detected in our study, which is hemangiopericytoma in a 15-year-old male patient. The epidemiological profile of brain tumors in Morocco and more specifically in the Rabat-Salé-Kenitra region has similarities with other studies in Morocco and also presents differences. However, other multicenter studies are necessary in our country to establish a Moroccan national registry of brain tumors that can be used for other epidemiological studies on a continental scale.
脑肿瘤是指在脑实质中发生的所有肿瘤，包括良性和恶性。在非洲，包括摩洛哥，缺乏描述脑肿瘤的数据。本研究的目的是描述摩洛哥青少年脑肿瘤类型的流行病学概况。我们的研究是一项描述性流行病学研究，针对的是2020年1月1日至12月31日在ju - rabat - mo - rocco专科医院神经外科收治的所有10至19岁的脑肿瘤患者。在此期间，神经外科接收了179名诊断为脑肿瘤的患者，其中包括18名青少年，占所有入院患者的10.05%。其中女性11例，男性7例，男女性别比为0.64。患者平均年龄13.05岁，四肢10 - 19岁不等。我们发现，在肿瘤的地理分布上，50%的肿瘤位于幕下，50%位于幕上。最明显的症状是头痛(12例，66.67%)。其他症状有:乏力(11例)、头晕(10例)、呕吐(8例)、体重减轻(8例)、癫痫发作(6例)、视力障碍(5例)、平衡障碍(4例)、偏瘫(3例)、听觉减退(2例)等。星形细胞瘤占诊断肿瘤的首位，占22.22%，其次是前庭神经鞘瘤和颅咽管瘤，各占16.67%。地形诊断发现幕下定位等于幕上定位各50%。在我们的研究中发现了一个罕见的肿瘤，这是一个15岁的男性患者的血管外皮细胞瘤。摩洛哥，特别是拉巴特-萨尔萨姆-凯尼特拉地区脑肿瘤的流行病学概况与摩洛哥的其他研究有相似之处，但也存在差异。然而，为了建立摩洛哥国家脑肿瘤登记处，在我国还需要进行其他多中心研究，以便在整个大陆范围内进行其他流行病学研究。
{"title":"BRAIN TUMORS AMONG MOROCCAN ADOLESCENTS IN THE REGION OF RABAT-SALE-KENITRA, MOROCCO","authors":"M. Legmouz, A. El Ouahabi, S. Boulbaroud, F. Azzaoui","doi":"10.5604/01.3001.0016.0760","DOIUrl":"https://doi.org/10.5604/01.3001.0016.0760","url":null,"abstract":"Brain tumours refer to all tumors, both benign and malignant, which develop in the cerebral parenchyma. In Africa, including Morocco, there is a paucity of descriptive brain tumors data. The aim of this study to describe the epidemiological profile of brain tumors types among Moroccan adolescents.\u0000\u0000Our study is a descriptive epidemiological study targeting all ado- lescent patients, aged between 10 and 19, suffering from a brain tumor and admitted from January 1 to December 31, 2020, to the neuro- surgery department of the Hospital of Specialities-CHU-Rabat-Mo- rocco.\u0000\u0000During these period, the neurosurgery department admitted 179 patients diagnosed with a brain tumor, including 18 adolescents, which represents 10.05% of all admitted patients. The 18 teenagers found include 11 females patients and 7 males patients which means a sex-ratio Male/Female of 0,64. The average age of our patients is 13.05 years, with extremities ranging from 10 to 19 years. It was found that for the topographic distribution 50% of tumors are infratentorial and 50% are supratentorial. The most presented re- vealing symptomatology is headaches (12 patients, 66.67%). The other symptoms experienced by patients were fatigability (11 patients), diziness (10 patients), vomiting (8 patients), weightloss (8 patients), seizures (6 patients), visual disturbances (5 patients), balance disorder (4 patients), hemiparesis (3 patients), hypoacusis (2 patients) and other. We found that Astrocytomas come in first position of diagnosed tumors with a percentage of 22.22% followed by Vestibular schwannoma and Craniopharyngioma with a percentage of 16.67% each. The topographic diagnosis finds an infra-tentorial localization equal to the supratentorial localization with 50% each. A rare tumor was detected in our study, which is hemangiopericytoma in a 15-year-old male patient.\u0000\u0000The epidemiological profile of brain tumors in Morocco and more specifically in the Rabat-Salé-Kenitra region has similarities with other studies in Morocco and also presents differences. However, other multicenter studies are necessary in our country to establish a Moroccan national registry of brain tumors that can be used for other epidemiological studies on a continental scale.\u0000\u0000","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46505313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-25DOI: 10.5604/01.3001.0015.9724
Ksenia Cielebąk, A. Gawronska, Łukasz Barwiński, Dariusz Skorupa
Early evidence described by a number of scholars worldwide suggests that neuroCOVID-19 has both mild [e.g. loss of smell (anosmia), loss of taste (ageusia), neurological tics (heterophilia), visual disturbances, headaches, dizziness, disorientation] and more severe sequelae (e.g. cognitive impairment, seizures, delirium, psychosis, strokes). Long-term neurological problems or neurological deficits may also occur. The aim of this study was to describe the examination and neurotherapy of a boy following SARS-CoV-2 infection and NeuroCOVID-19 in whom neurological tics and motor automatisms as well as cognitive impairment, particularly attention deficit disorder, developed as a consequence. We present a boy K.S., 7 years old, without any neurodevelopmental disorders, following a SARS-CoV-2 infection in May 2021 and the contraction of neuroCOVID-19 confirmed by a genetic test for the quantitative detection of neutralising antibodies (responsible for immunity) in the IgG class against SARS-CoV-2. The boy had relatively mild pseudomonal symptoms of the illness: temperature 38.5, runny nose, cough, muscle aches, headaches and general weakness. He was treated symptomatically and recovered after 2 weeks. Two months later, at the beginning of July 2021, neurological tics consisting of an upward turning of the eyeballs to the left appeared. These tics intensified in August 2021 and were accompanied by motor automatisms consisting of the left hand stiffening in a salute-like position, while at the same time there was an inclination of the head to the left. In September 2021, after exertion in the swimming pool, an epileptic seizure occurred which caused the boy to start drowning. In the days that followed the above described tics and motor automatisms increased. He also developed sleep disorders, which consisted of him waking up several times during the night, during which time neurological tics and motor automatisms also appeared. Gradually, cognitive dysfunctions, especially attention deficits and behavioural changes, joined in, making it impossible for the boy to function independently at school and in many situations of daily life. Neurophysiological examination: qEEG, ERPs and sLORETA tomography performed on 11.09. 2021 using automatic seizure activity detection software showed the presence of the neuromarker benign partial rolandic epilepsy (BPERS) and neurocognitive disturbances resembling the symptoms of attention deficit hyperactivity disorder (ADHD), compared with the neuromarkers of children with this condition (n=100) from the normative database of the Human Brain Index (HBI) in Switzerland. Detection of the neuromarkerBPERS was helpful in selecting an individualised neurostimulation protocol. The patient participated in 20 neurofeedback sessions using (1) SMR reinforcement, theta inhibition; (2) theta inhibition, B1 reinforcement (15-18 Hz); (3) qEEG-guided neurofeedback. Neurostimulation with neurofeedback was conducted twice a week, for 15-20
{"title":"BENIGN PARTIAL ROLANDIC EPILEPSY FOLLOWING SARS-COV-2 INFECTION AND NEUROCOVID-19 EXPERIENCE: A CASE STUDY","authors":"Ksenia Cielebąk, A. Gawronska, Łukasz Barwiński, Dariusz Skorupa","doi":"10.5604/01.3001.0015.9724","DOIUrl":"https://doi.org/10.5604/01.3001.0015.9724","url":null,"abstract":"Early evidence described by a number of scholars worldwide suggests that neuroCOVID-19 has both mild [e.g. loss of smell (anosmia), loss of taste (ageusia), neurological tics (heterophilia), visual disturbances, headaches, dizziness, disorientation] and more severe sequelae (e.g. cognitive impairment, seizures, delirium, psychosis, strokes). Long-term neurological problems or neurological deficits may also occur. The aim of this study was to describe the examination and neurotherapy of a boy following SARS-CoV-2 infection and NeuroCOVID-19 in whom neurological tics and motor automatisms as well as cognitive impairment, particularly attention deficit disorder, developed as a consequence.\u0000\u0000We present a boy K.S., 7 years old, without any neurodevelopmental disorders, following a SARS-CoV-2 infection in May 2021 and the contraction of neuroCOVID-19 confirmed by a genetic test for the quantitative detection of neutralising antibodies (responsible for immunity) in the IgG class against SARS-CoV-2. The boy had relatively mild pseudomonal symptoms of the illness: temperature 38.5, runny nose, cough, muscle aches, headaches and general weakness. He was treated symptomatically and recovered after 2 weeks. Two months later, at the beginning of July 2021, neurological tics consisting of an upward turning of the eyeballs to the left appeared. These tics intensified in August 2021 and were accompanied by motor automatisms consisting of the left hand stiffening in a salute-like position, while at the same time there was an inclination of the head to the left. In September 2021, after exertion in the swimming pool, an epileptic seizure occurred which caused the boy to start drowning. In the days that followed the above described tics and motor automatisms increased. He also developed sleep disorders, which consisted of him waking up several times during the night, during which time neurological tics and motor automatisms also appeared. Gradually, cognitive dysfunctions, especially attention deficits and behavioural changes, joined in, making it impossible for the boy to function independently at school and in many situations of daily life. Neurophysiological examination: qEEG, ERPs and sLORETA tomography performed on 11.09. 2021 using automatic seizure activity detection software showed the presence of the neuromarker benign partial rolandic epilepsy (BPERS) and neurocognitive disturbances resembling the symptoms of attention deficit hyperactivity disorder (ADHD), compared with the neuromarkers of children with this condition (n=100) from the normative database of the Human Brain Index (HBI) in Switzerland. Detection of the neuromarkerBPERS was helpful in selecting an individualised neurostimulation protocol. The patient participated in 20 neurofeedback sessions using (1) SMR reinforcement, theta inhibition; (2) theta inhibition, B1 reinforcement (15-18 Hz); (3) qEEG-guided neurofeedback. Neurostimulation with neurofeedback was conducted twice a week, for 15-20 ","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48766227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-15DOI: 10.5604/01.3001.0015.8750
H. Khalki, J. Ouirari, S. Boulbaroud, Hamid Karim, O. Abboussi, L. Khalki
Due to the Covid-19 pandemic Morocco had to introduce very drastic measures such as quarantine, social distancing or massive restriction of public life in order to prevent the collapse of the health system due to the rapid spread of the disease. This descriptive and analytical study was conducted during strict quarantine among Moroccan adults aged 18 to 63 years (n=990)to examine the psychological impact of Covid-19 pandemic in Moroccan population. They responded to online survey including three items; socio-demographic status, health status and a modified version of Hospital Anxiety and Depression scale (HADs). We found a high prevalence of anxiety 40.5% and depression 28,9%. Young participants aged below 30 were more likely to have anxiety (59,1%) and depression symptoms (50%). The prevalence of this symptoms was higher in women (66,8%) compared to men. Individuals with higher education degree tend to be more anxious (65,1%) and depressed (63,3%) compared by those with secondary (26,7% anxious, 28% depressed) and elementary education level (8,2% anxious, 8,7% depressed). Covid-19 pandemic caused a new economical, medical and social conditions, altered the quality of life of Moroccan population and caused a higher prevalence mental health like fear, anxiety and depression.
{"title":"PREVALENCE OF SYMPTOMS OF ANXIETY, DEPRESSION AND ASSOCIATED SOCIO-DEMOGRAPHIC FACTORS DURING THE COVID-19 PANDEMIC IN MOROCCO","authors":"H. Khalki, J. Ouirari, S. Boulbaroud, Hamid Karim, O. Abboussi, L. Khalki","doi":"10.5604/01.3001.0015.8750","DOIUrl":"https://doi.org/10.5604/01.3001.0015.8750","url":null,"abstract":"Due to the Covid-19 pandemic Morocco had to introduce very drastic measures such as quarantine, social distancing or massive restriction of public life in order to prevent the collapse of the health system due to the rapid spread of the disease.\u0000\u0000This descriptive and analytical study was conducted during strict quarantine among Moroccan adults aged 18 to 63 years (n=990)to examine the psychological impact of Covid-19 pandemic in Moroccan population. They responded to online survey including three items; socio-demographic status, health status and a modified version of Hospital Anxiety and Depression scale (HADs).\u0000\u0000We found a high prevalence of anxiety 40.5% and depression 28,9%. Young participants aged below 30 were more likely to have anxiety (59,1%) and depression symptoms (50%). The prevalence of this symptoms was higher in women (66,8%) compared to men. Individuals with higher education degree tend to be more anxious (65,1%) and depressed (63,3%) compared by those with secondary (26,7% anxious, 28% depressed) and elementary education level (8,2% anxious, 8,7% depressed).\u0000\u0000Covid-19 pandemic caused a new economical, medical and social conditions, altered the quality of life of Moroccan population and caused a higher prevalence mental health like fear, anxiety and depression.\u0000\u0000","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49030190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-15DOI: 10.5604/01.3001.0015.9144
M. Pąchalska, Jolanta Góral-Półrola
Recent advances in neuroscience have allowed researchers to introduce functional neuromarkers of autism spectrum disorders (ASD) into clinical practice. Most promising are studies of brain work in milliseconds, such as quantitative EEGs, event-related potentials (ERPs), low resolution electromagnetic tomography(sLORETA), especially when it is possible to use Human Brain Index (HBI) methodology to compare test results obtained by a child with ASD with the normative database. The use of HBI methodology make possible to determine functional neuromarkers of ASD and comorbidities, such as epilepsy, impaired cognitive and emotional control or executive function (FF) disorders. Such procedure can contribute to more effective diagnosis, as well as provide personalized care for patients with ASD. In this case study we use the HBI methodology for more effective diagnosis of the child with ASD (level 2) with focal epilepsy and EF dysfunction in hope that we can provide more effective therapies which might improve her quality of life. We present the case of a 11-years-old girl with an initial diagnosis of ASD with focal epilepsy and EF dysfunction. The patient was sent to the Teaching-Reintegration Centre in Kraków with remarks that she simply could not function in everyday life. A neuropsychological examination using standardized batteries to assess the girl's cognitive, emotional and social functioning confirmed the presence of ASD (level 2), and co-occurring executive function disorders (EF). She was also analyzed from the clinical EEG perspective as well as from the QEEG/ERPs perspective and current coexistence of 3 Hz Spike-Wave Discharges on EEG and focal epilepsy was found. In the examination several episodes of 3 Hz paroxysms were found in the ventro-lateral prefrontal cortex (BA 11) in 40 min EEG recoding in Eyes open, Eyes closed as well as in task conditions. The patient’s ERPs showed that to the first stimulus (continue cue) temporal P2 wave with larger duration and longer latency was elicited in comparison to the average of the norm for her age from the Human Brain Index (HBI) normative database at Chur, Switzerland. The P30 cue was smaller in the patient than in the healthy controls from HBI and statistically significant deviations from the average were found. Also in response to NOGO stimulus no positive parietal-central P3 was observed, which appears in the ERPs of ealthy controls from HBI. The ERPs differences in the VCPT show statistically significant deviations in the patient’s brain function when compared to the ealthy controls from HBI. It should be stressed that the number of trials for the first stimulus presentation and NOGO condition were large enough for computing reliable ERPs, as it was indicated by Kropotov (2009; 2016). HBI methodology was helpful in finding functional neuromarkers of co-existence of 3 Hz Spike-Wave Discharges on EEG with focal epilepsy and EF disorder in girl with ASD (level 2). Therefore, it was possible to
{"title":"FOCAL EPILEPSY AND EXECUTIVE DYSFUNCTION IN AUTISM SPECTRUM DISORDER (ASD)","authors":"M. Pąchalska, Jolanta Góral-Półrola","doi":"10.5604/01.3001.0015.9144","DOIUrl":"https://doi.org/10.5604/01.3001.0015.9144","url":null,"abstract":"Recent advances in neuroscience have allowed researchers to introduce functional neuromarkers of autism spectrum disorders (ASD) into clinical practice. Most promising are studies of brain work in milliseconds, such as quantitative EEGs, event-related potentials (ERPs), low resolution electromagnetic tomography(sLORETA), especially when it is possible to use Human Brain Index (HBI) methodology to compare test results obtained by a child with ASD with the normative database. The use of HBI methodology make possible to determine functional neuromarkers of ASD and comorbidities, such as epilepsy, impaired cognitive and emotional control or executive function (FF) disorders. Such procedure can contribute to more effective diagnosis, as well as provide personalized care for patients with ASD. In this case study we use the HBI methodology for more effective diagnosis of the child with ASD (level 2) with focal epilepsy and EF dysfunction in hope that we can provide more effective therapies which might improve her quality of life.\u0000\u0000We present the case of a 11-years-old girl with an initial diagnosis of ASD with focal epilepsy and EF dysfunction. The patient was sent to the Teaching-Reintegration Centre in Kraków with remarks that she simply could not function in everyday life. A neuropsychological examination using standardized batteries to assess the girl's cognitive, emotional and social functioning confirmed the presence of ASD (level 2), and co-occurring executive function disorders (EF). She was also analyzed from the clinical EEG perspective as well as from the QEEG/ERPs perspective and current coexistence of 3 Hz Spike-Wave Discharges on EEG and focal epilepsy was found. In the examination several episodes of 3 Hz paroxysms were found in the ventro-lateral prefrontal cortex (BA 11) in 40 min EEG recoding in Eyes open, Eyes closed as well as in task conditions. The patient’s ERPs showed that to the first stimulus (continue cue) temporal P2 wave with larger duration and longer latency was elicited in comparison to the average of the norm for her age from the Human Brain Index (HBI) normative database at Chur, Switzerland. The P30 cue was smaller in the patient than in the healthy controls from HBI and statistically significant deviations from the average were found. Also in response to NOGO stimulus no positive parietal-central P3 was observed, which appears in the ERPs of ealthy controls from HBI. The ERPs differences in the VCPT show statistically significant deviations in the patient’s brain function when compared to the ealthy controls from HBI. It should be stressed that the number of trials for the first stimulus presentation and NOGO condition were large enough for computing reliable ERPs, as it was indicated by Kropotov (2009; 2016).\u0000\u0000HBI methodology was helpful in finding functional neuromarkers of co-existence of 3 Hz Spike-Wave Discharges on EEG with focal epilepsy and EF disorder in girl with ASD (level 2). Therefore, it was possible to ","PeriodicalId":43280,"journal":{"name":"Acta Neuropsychologica","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46731285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：